[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630160":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":30,"responsibleParty":49,"collaborators":51,"id":54,"slug":11,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":11,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":11,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Olistic Research Labs S.L.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Product Arm","EXPERIMENTAL",null,[13],"Dietary Supplement: Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45.",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo Arm","PLACEBO_COMPARATOR",[18],"Other: Placebo control",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DIETARY_SUPPLEMENT","Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45.","Drinkable multifactorial food supplement in liquid form, administered once daily in a 25 mL single-dose vial, for a duration of 180 days. The formulation contains a combination of vitamins, minerals, amino acids, plant extracts, and other bioactive compounds designed to support hair growth and scalp health in women +45.",[9],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":11},"OTHER","Placebo control","Drinkable formulation consisting of an excipient formulation designed to mimic the organoleptic properties of the active product, reproducing its color and texture while achieving a highly similar taste profile.",[15],[31],{"facility":32,"status":33,"city":34,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Grupo Dermatologico Y Estetico Pedro Jaen S.A.","RECRUITING","Madrid","28006","Spain",{"type":38,"coordinates":39},"Point",[40,41],-3.70256,40.4165,{"lat":41,"lon":40},[44],{"name":45,"role":46,"phone":47,"phoneExt":11,"email":48},"Leyre Malet, PhD","CONTACT","+34 617862464","info@icmrresearch.com",{"type":50,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[52],{"name":32,"class":53},"UNKNOWN","100630160",false,"NCT07484061","Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1\u002FGIP Receptor Agonists","Evaluation of the Efficacy and Safety of a Drinkable Nutraceutical in Improving Hair Loss in Patients Treated With GLP-1\u002FGIP Receptor Agonists: a Double-blind, 1:1 Randomized, Placebo-controlled Study.","Inclusion Criteria:\n\n* Female gender.\n* Age \\>35 years.\n* Initiation of treatment with a GLP-1\u002FGIP agonist, or treatment duration \\\u003C 3 months, as per routine clinical practice in the endocrinology clinic.\n* Having signed the participant information sheet and the written informed consent and having been informed of the objective of the study.\n* Additional criteria to be included by the client.\n\nExclusion Criteria:\n\n* Allergy or hypersensitivity to any of the components of the product, or to a product from a similar category to the one being tested.\n* Scalp diseases: cicatricial alopecia, alopecia areata, folliculitis decalvans, psoriasis, moderate to severe seborrheic dermatitis, eczema, cancer, etc.\n* Women presenting alopecia due to an underlying medical condition (hypothyroidism, anemia, lupus, etc.).\n* Pharmacological treatment that may promote the onset of telogen effluvium, initiated within the 3 months prior to study start (e.g., valproic acid, carbamazepine, phenytoin, selective serotonin reuptake inhibitors, oral anticoagulants, retinoids, beta-blockers). Patients who have undergone a dose change of these medications within the same period are also excluded.\n* Women with uncontrolled thyroid disorders (hyperthyroidism or hypothyroidism) within the 6 months prior to study initiation.\n* Women who have used anti-hair loss products within the last 3 months.\n* Women who have initiated or undergone dermatological treatment for hair loss within the last 6 months (minoxidil, finasteride, PRP, mesotherapy, etc.).\n* Women who have undergone hair transplantation within the 18 months prior to study initiation.\n* Women who have initiated treatment with anxiolytics, antidepressants, amphetamines, ACE inhibitors, or iron within the last 3 months.\n* Women who initiated or discontinued hormonal treatment (oral contraceptives, oral or topical hormone replacement therapy, ovarian stimulation) within the 3 months prior to study initiation.\n* Pregnant women, postpartum women (within 6 months), breastfeeding women, or women planning to become pregnant during the study period.\n* Additional exclusion criteria to be specified by the sponsor.\n* Any condition that, in the investigator's opinion, makes participation in the study inappropriate.","FEMALE","35 Years",{"count":63,"type":64},40,"ESTIMATED","INTERVENTIONAL",[67],"NA","The purpose of this clinical trial is to evaluate the efficacy of Olistic© Next Women, a nutraceutical supplement, compared with placebo in improving hair loss in patients undergoing treatment with GLP-1\u002FGIP agonists. This 6-month, randomized, placebo-controlled clinical study investigates whether daily supplementation with Olistic© Next Women leads to significant improvements in hair loss in this patient population. In addition, the study assesses the safety and tolerability of the product throughout the treatment period.",[70],"Telogen Effluvium","2026-03-19",{"date":73,"type":74},"2026-03-23","ACTUAL",{"date":76,"type":74},"2026-03-16",{"date":78,"type":64},"2026-10-31",{"name":5,"class":6},1]